Getagraph.com logo
S&P 500
(0.08%) 5 104.15 points
Dow Jones
(0.24%) 38 331 points
Nasdaq
(0.10%) 15 943 points
Oil
(-1.29%) $82.77
Gas
(6.50%) $2.05
Gold
(-0.06%) $2 345.90
Silver
(-0.36%) $27.44
Platinum
(3.84%) $957.55
USD/EUR
(-0.19%) $0.933
USD/NOK
(-0.30%) $10.99
USD/GBP
(-0.52%) $0.796
USD/RUB
(1.70%) $93.44

Actualizaciones en tiempo real para NeuroMetrix Inc [NURO]

Bolsa: NASDAQ Sector: Healthcare Industria: Medical Devices
Upcoming Earnings Alert

2 days till quarter result
(bmo 2024-05-01)

Expected move: +/- 14.14%

Última actualización29 abr 2024 @ 14:06
25% discount on Stockinvest.us - Use code: Podcast

1.61% $ 4.51

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 14:06):

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico...

Stats
Volumen de hoy 7 875.00
Volumen promedio 50 182.00
Capitalización de mercado 8.96M
EPS $0 ( 2024-02-22 )
Próxima fecha de ganancias ( $0 ) 2024-05-01
Last Dividend $1 728.00 ( 2007-03-28 )
Next Dividend $0 ( N/A )
P/E -0.720
ATR14 $0.0430 (0.95%)
Insider Trading
Date Person Action Amount type
2024-04-18 Horowitz Joshua Buy 16 438 Common Stock
2024-04-18 Horowitz Joshua Buy 0 Common Stock
2024-04-18 Horowitz Joshua Sell 0 Common Stock
2024-04-01 Higgins Thomas T Buy 469 Common Stock
2024-04-01 Higgins Thomas T Sell 74 Common Stock
INSIDER POWER
54.21
Last 97 transactions
Buy: 971 558 | Sell: 254 579

NeuroMetrix Inc Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

NeuroMetrix Inc Finanzas

Annual 2023
Ingresos: $5.90M
Beneficio Bruto: $3.95M (66.89 %)
EPS: $-6.27
FY 2023
Ingresos: $5.90M
Beneficio Bruto: $3.95M (66.89 %)
EPS: $-6.27
FY 2022
Ingresos: $8.26M
Beneficio Bruto: $5.75M (69.65 %)
EPS: $-4.90
FY 2021
Ingresos: $8.25M
Beneficio Bruto: $5.92M (71.75 %)
EPS: $-0.342

Financial Reports:

No articles found.

NeuroMetrix Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A)

NeuroMetrix Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $1 728.00 2007-03-28
Last Dividend $1 728.00 2007-03-28
Next Dividend $0 N/A
Payout Date 2007-04-13
Next Payout Date N/A
# dividends 1 --
Total Paid Out $1 728.00 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
 (2024-04-29)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield
2007 $1.000 0.00%
2008 $0 0.00%
2009 $0 0.00%
2010 $0 0.00%
2011 $0 0.00%
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-1.0831.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.2981.200-9.95-10.00[0 - 0.3]
returnOnEquityTTM-0.3071.500-4.52-6.78[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM16.810.80010.008.00[1 - 3]
quickRatioTTM14.920.80010.008.00[0.8 - 2.5]
cashRatioTTM1.3961.5003.365.03[0.2 - 2]
debtRatioTTM0.0112-1.5009.81-10.00[0 - 0.6]
interestCoverageTTM52.631.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM-3.992.00-1.330-2.66[0 - 30]
freeCashFlowPerShareTTM-4.112.00-2.06-4.11[0 - 20]
debtEquityRatioTTM0.0120-1.5009.95-10.00[0 - 2.5]
grossProfitMarginTTM0.6691.0002.192.19[0.2 - 0.8]
operatingProfitMarginTTM-1.2121.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-25.261.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM0.2750.800-1.497-1.198[0.5 - 2]
Total Score-0.253

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-1.0591.000-0.2080[1 - 100]
returnOnEquityTTM-0.3072.50-2.90-6.78[0.1 - 1.5]
freeCashFlowPerShareTTM-4.112.00-1.370-4.11[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-3.992.00-1.330-2.66[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.03611.500-3.570[0.5 - 2]
operatingCashFlowSalesRatioTTM-1.0311.000-10.000[0.1 - 0.5]
Total Score-2.82

NeuroMetrix Inc

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico